BASEJUMPER
LIVE

Serial Number

90979307

Owner

BIOSKRYB GENOMICS, INC.

Attorney

Samantha C. Markley

First Use Date

Nov 9, 2022

Filing Date

Mar 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BASEJUMPER Trademark

Serial Number: 90979307 • Registration: 7032252

BASEJUMPER is a trademark filed by BIOSKRYB GENOMICS, INC. on March 24, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BIOSKRYB GENOMICS, INC. (7 trademarks)

Durham, NC 27713

Entity Type: 03

BioSkryb, Inc. (7 trademarks)

701 West Main Street, Suite 200
Durham, NC 27701

Entity Type: 03

Trademark Details

Filing Date

March 24, 2021

Registration Date

April 18, 2023

First Use Anywhere

November 9, 2022

First Use in Commerce

November 9, 2022

Published for Opposition

March 8, 2022

Goods & Services

Genomic, proteomic, transcriptomic, epigenomic, metabolomic, and microbiomic analysis and sequencing services for scientific and research purposes; providing scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for scientific research purposes; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; providing temporary use of non-downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; providing temporary use of non-downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; providing temporary use of non-downloadable computer software for medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; providing temporary use of non-downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing temporary use of non-downloadable computer software for use in connection with medical diagnostic testing, monitoring, and reporting; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in connection with the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of gene therapy and cell therapy; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2026 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 11, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2026 REAP
WITHDRAWAL OF ATTORNEY GRANTED
Feb 17, 2026 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Feb 17, 2026 WOAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 18, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 10, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 9, 2023 SUPC
DIVISIONAL PROCESSING COMPLETE
Mar 9, 2023 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2023 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 30, 2023 AITU
USE AMENDMENT FILED
Dec 29, 2022 IUAF
DIVISIONAL REQUEST RECEIVED
Dec 29, 2022 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Dec 29, 2022 ERTD
TEAS STATEMENT OF USE RECEIVED
Dec 29, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 31, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 31, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 31, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 3, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 1, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 17, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 17, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 17, 2021 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 26, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2021 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 2, 2021 ASGN
NEW APPLICATION ENTERED
Mar 27, 2021 NWAP